Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Price, Quote & AI Analysis
Live ARCT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Arcturus Therapeutics Holdings Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Arcturus Therapeutics Holdings Inc. Common Stock (ARCT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Arcturus Therapeutics Holdings Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Arcturus Therapeutics Holdings Inc. Common Stock Overview
Company information
Company Overview
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Arcturus Therapeutics Holdings Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...